We are sad to announce that the pharmaceutical company AVROBIO has made the difficult decision to deprioritize its gene therapy trial for Fabry disease. It is another in a line of disappointments for
new therapies in the last year and it is hard on the Fabry community that we support.
If you need to speak to a member of the Support and Advocacy Team, please call 0345 389 9901.
You can read the full press release from AVROBIO here.
